Biosphere
PrivateLast Round
Grant
May 5, 2026
Total Funding Raised
$17.8M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Biosphere operates in Healthcare & Life Sciences and is based in Oakland, California. Its latest recorded funding round was a Grant round in May 2026.
Biosphere is a biotechnology company that develops and manufactures UV-enabled bioreactor systems designed to reduce the capital intensity of industrial biomanufacturing for products such as therapeutics, enzymes, proteins, bioplastics, and fertilizers.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Defense Tech, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biosphere Comparables
Compare Biosphere with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Curve | 80% | |
| InFamily Foods | 78% | |
| Fermeate | 71% |
For institutional investors. Book with your work email.
Biosphere Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 5, 2026 | ||||
| Seed | Jan 9, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biosphere Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Also Capital | Seed |
| B37 Ventures | Seed |
| GS Futures | Seed |
| Founders Fund | Seed |
| VXI Capital | Seed |
| U.S. Department of War | Grant |
| Lowercarbon Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Grew 24% QoQ, from 21 to 26 employees.
- Jul 17, 2026
Grew 28% QoQ, from 18 to 23 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- invests_into_assetsOct 28, 2026
Biosphere invests $21M into a new 20,000-liter facility slated for commissioning in Q4 '27.
- is_developingOct 28, 2026
The Pentagon awards Biosphere up to $9 million, if all options are exercised, to develop a portable, electrically powered bio-brewery that makes protein from water and air.
- signs_new_clientOct 28, 2026
Biosphere secures a $21 million United States Department of War contract to prototype, commission, and operate 20,000-liter industrial bioreactors for biomanufacturing critical chemicals in California on Oct 28th '26.
- is_developingOct 28, 2026
Biosphere is developing a flexible biomanufacturing platform that combines advanced bioreactor architectures, process intensification, and proprietary automation and control systems to reduce biomanufacturing capital and operating costs.
- receives_financingOct 28, 2026
Biosphere receives a $21M Department of War contract on Oct 28th '26 in California to prototype, commission, and operate industrial bioreactors for domestic production of critical chemicals and materials.
For institutional investors. Book with your work email.
Biosphere Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biosphere's valuation, stock price, and market status.
Is Biosphere a public or private company?
Biosphere is a private company.
What is the current stock price of Biosphere?
Biosphere is a private company, so its shares have no public market price. Caplight tracks Biosphere's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biosphere worth (valuation)?
Valuation information for Biosphere is not publicly available.
Can I buy Biosphere stock?
Biosphere shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biosphere's last funding round?
Biosphere's most recent funding round was Grant on May 5, 2026.
Who are the main investors in Biosphere?
Key investors in Biosphere include VXI Capital, Lowercarbon Capital.
Will Biosphere IPO soon?
No public IPO plans have been announced for Biosphere.
How can I track Biosphere secondary market activity?
Caplight tracks bids, offers, and trades in Biosphere's shares on secondary markets.